Abstract
Protein aggregation is facilitated by the generation of partially folded intermediates that lack most of the tertiary interactions, but retain the complete secondary structure. These partially folded states cross-link each other to form protein aggregates. Protein aggregates in an advanced stage result in the formation of amyloid fibrils, which have high tensile strength. These amyloid fibrils are associated with a number of pathologies, especially Alzheimer’s disease, which involves the aggregation of the Aβ peptide. In recent years, much attention has been paid to the generation of potent therapeutics to reduce Aβ peptide fibrillation. This review summarizes the range of molecules used for this therapy, showing their potency against Aβ amyloids, and suggests a positive future for the eradication of this dreaded disease.
Keywords: Aβ peptide, Alzheimer’s disease, amyloid fibrils, protein aggregates, nanotechnological approach.
Current Drug Metabolism
Title:Therapeutic Interventions for the Suppression of Alzheimer’s Disease: Quest for a Remedy
Volume: 16 Issue: 5
Author(s): Naveed Ahmad Fazili, Aabgeena Naeem, Ghulam Md. Ashraf, Siew Hua Gan and Mohammad A. Kamal
Affiliation:
Keywords: Aβ peptide, Alzheimer’s disease, amyloid fibrils, protein aggregates, nanotechnological approach.
Abstract: Protein aggregation is facilitated by the generation of partially folded intermediates that lack most of the tertiary interactions, but retain the complete secondary structure. These partially folded states cross-link each other to form protein aggregates. Protein aggregates in an advanced stage result in the formation of amyloid fibrils, which have high tensile strength. These amyloid fibrils are associated with a number of pathologies, especially Alzheimer’s disease, which involves the aggregation of the Aβ peptide. In recent years, much attention has been paid to the generation of potent therapeutics to reduce Aβ peptide fibrillation. This review summarizes the range of molecules used for this therapy, showing their potency against Aβ amyloids, and suggests a positive future for the eradication of this dreaded disease.
Export Options
About this article
Cite this article as:
Ahmad Fazili Naveed, Naeem Aabgeena, Md. Ashraf Ghulam, Hua Gan Siew and A. Kamal Mohammad, Therapeutic Interventions for the Suppression of Alzheimer’s Disease: Quest for a Remedy, Current Drug Metabolism 2015; 16 (5) . https://dx.doi.org/10.2174/1389200215999141125115749
DOI https://dx.doi.org/10.2174/1389200215999141125115749 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Overview on Potential Neuroprotective Compounds for Management of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Role of Vitamin D in the Pathophysiology and Treatment of Type 2 Diabetes
Current Diabetes Reviews Infertile Women's Perceptions of Infertility: A Phenomenological Study Based on Metaphor Analysis
Current Women`s Health Reviews Hormones in the Mentally Disturbed Brain: Steroids and Peptides in the Development and Treatment of Psychopathology
Central Nervous System Agents in Medicinal Chemistry Tph2 Genetic Ablation Contributes to Senile Plaque Load and Astrogliosis in APP/PS1 Mice
Current Alzheimer Research “Speed” Warps Time: Methamphetamines Interactive Roles in Drug Abuse, Habit Formation, and the Biological Clocks of Circadian and Interval Timing
Current Drug Abuse Reviews Patient Involvement and Shared Decision-Making in Mental Health Care
Current Clinical Pharmacology Cyclodextrin-Based Carriers for Topical Delivery of Anti-Inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry γ-AApeptides as a New Strategy for Therapeutic Development
Current Medicinal Chemistry A Current Perspective on the Inhibition of Cholinesterase by Natural and Synthetic Inhibitors
Current Drug Metabolism Biochemistry and Physiology of Anabolic Androgenic Steroids Doping
Mini-Reviews in Medicinal Chemistry STIP Regulates ERK1/2 Signaling Pathway Involved in Interaction with PP1γ in Lymphoblastic Leukemia
Current Molecular Medicine Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Editorial (Thematic Issue: Current Perspectives and Challenges in Design, Chemistry and Pharmacology of Opioids)
Current Pharmaceutical Design Rehab of NAD(P)-Dependent Enzymes with NAD(P)-Based Inhibitors
Current Medicinal Chemistry Clinical Aspects and Therapeutic Perspectives of Relaxin
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies
Central Nervous System Agents in Medicinal Chemistry Membrane Interacting Peptides: From Killers to Helpers
Current Protein & Peptide Science Placebo Effects in Therapeutic Outcomes
Current Clinical Pharmacology Brain Adaptation to Stressful Stimuli: A New Perspective on Potential Therapeutic Approaches Based on BDNF and NMDA Receptors
CNS & Neurological Disorders - Drug Targets